CIK 0000887359
- Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- Operating
- EIN
- 943096597
- Phone
- +1 617-588-5555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,896,581
- in 8 filings, $5.8M under 10b5-1 plans
Net −$5,896,581. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$188K Principal Accounting Officer sold 73% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-30 | Hopper Jonathan Mark Chief Medical Officer | Sale | −134 | $57.14 | $8K | 39,319 |
| 2021-05-14 | Wotton Paul K Director | Sale | −5,000 | $50.52 | $253K | 26,602 |
| 2021-05-12 | Wotton Paul K Director | Sale | −2,200 | $48.88 | $108K | 31,602 |
| 2021-05-11 | Wotton Paul K Director | Sale | −13,448 | $50.11 | $674K | 33,802 |
| 2021-04-19 | Colangelo Dominick President and CEO | Sale | −8,990 | $59.13 | $532K | 166,420 |
| 2021-04-19 | Colangelo Dominick President and CEO | Sale | −14,760 | $57.92 | $855K | 159,223 |
| 2021-04-19 | Colangelo Dominick President and CEO | Sale | −16,250 | $57.46 | $934K | 142,973 |
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Sale | −5,000 | $50.56 | $253K | 22,966 |
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Sale | −1,820 | $51.00 | $93K | 29,584 |
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Sale | −11,104 | $51.84 | $576K | 38,480 |
| 2021-03-29 | Colangelo Dominick President and CEO | Sale | −1,010 | $51.36 | $52K | 206,540 |
| 2021-03-29 | Colangelo Dominick President and CEO | Sale | −15,552 | $51.09 | $795K | 190,988 |
| 2021-03-29 | Colangelo Dominick President and CEO | Sale | −10,313 | $50.93 | $525K | 180,675 |
| 2021-03-29 | Colangelo Dominick President and CEO | Sale | −13,125 | $50.94 | $669K | 167,550 |
| 2021-03-01 | Colangelo Dominick President and CEO | Sale | −1,548 | $48.47 | $75K | 217,647 |
| 2021-03-01 | Colangelo Dominick President and CEO | Sale | −2,260 | $48.78 | $110K | 215,387 |
| 2021-03-01 | Colangelo Dominick President and CEO | Sale | −27,500 | $48.06 | $1.3M | 216,242 |
| 2021-03-01 | Colangelo Dominick President and CEO | Sale | −8,692 | $48.01 | $417K | 207,550 |
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Sale | −5,000 | $26.27 | $131K | 4,331 |
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Sale | −7,526 | $26.61 | $200K | 15,069 |
Page 9 of 14 · 279 trades